Tech Company Financing Transactions
BAIBYS Funding Round
BAIBYS secured a $4.5 million Series A funding round on 8/12/2024. Investors included Firstime Ventures and ROHTO Pharmaceutical.
Transaction Overview
Company Name
Announced On
8/12/2024
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Series A
Investors
Firstime Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations, its development efforts and business reach.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
26 Habarzel St.
Tel-Aviv, 6971036
Israel
Tel-Aviv, 6971036
Israel
Phone
Website
Email Address
Overview
BAIBYS' autonomous sperm selection solution for In-Vitro Fertilization (IVF) is designed to analyze living sperm cells in real-time using Machine Vision (MV) and Artificial Intelligence (AI). BAIBYS' system evaluates the cells according to morphological criteria, which can only be identified using high magnification.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Itay Itzhaky
Chief Executive Officer
Yaron Silberman
Chief Medical Officer
Nino Cassuto
Co-Founder
Gal Golov
VP - R & D
Nahum Budin
VP - Regulatory Affairs
David Rigler
Browse more venture capital transactions:
Prev: 8/12/2024: HealthCRED venture capital transaction
Next: 8/12/2024: Cosine venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records on this site come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs